A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

Signe Wildt, Inge Nordgaard Lassen, Ulla Hansen, Elke Brockmann, Jüri J Rumessen

129 Citations (Scopus)

Abstract

To investigate the clinical effect of treatment with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 (Probio-Tec AB-25) to maintain remission in patients with ulcerative colitis.
Original languageEnglish
JournalJournal of Crohn's & colitis
Volume5
Issue number2
Pages (from-to)115-21
Number of pages7
DOIs
Publication statusPublished - 1 Apr 2011

Fingerprint

Dive into the research topics of 'A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis'. Together they form a unique fingerprint.

Cite this